16,000 locally produced packages of a drug to treat multiple myeloma launched on the Russian market - Нанолек
3630-Multiple myeloma DVd (daratumumab bortezomib dexamethasone) overview | eviQ
Teclistamab Monotherapy for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma - touchONCOLOGY
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
ASCO 2016 Multiple Myeloma Update – Days One, Two, And Three
Multiple myeloma current treatment algorithms | Blood Cancer Journal
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
Cancers | Free Full-Text | Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab–Naïve Relapsed Multiple Myeloma
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion. - Abstract - Europe PMC
VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group - ScienceDirect
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study | BMC Cancer | Full Text
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
3630-Multiple myeloma DVd (daratumumab bortezomib dexamethasone) overview | eviQ
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma | Published in Journal of Health Economics and Outcomes Research
The DVD Regimen After Myeloma Progression
Frontiers | Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects
4144-Multiple myeloma DVd (daratumumab subcutaneous bortezomib dexamethasone) overview | eviQ
When and How to Treat Relapsed Multiple Myeloma | American Society of Clinical Oncology Educational Book
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma | Published in Journal of Health Economics and Outcomes Research
